LncRNA VIM-AS1 is a potential prognostic biomarker and effects on tumor cellular behaviors in breast cancer via impairing miR-29a-3p
VIM-AS1 exhibited aberrant expression in breast cancer, playing a critical role in tumor development by targeting miR-29a-3p. Our findings highlight the potential of VIM-AS1 as a novel diagnostic and prognostic biomarker in breast cancer. However, further in vivo studies and exploration of miR-29a-3p downstream targets are needed to fully elucidate the mechanistic role of VIM-AS1 in breast cancer progression.
Authors
- Linna Kong
- Wenqing Bian (ORCID: https://orcid.org/0009-0006-1458-2402)
- Teng Wei (ORCID: https://orcid.org/0000-0003-3860-200X)
- Pengfei Li (ORCID: https://orcid.org/0000-0003-1334-8770)
- Huihui Zhang (ORCID: https://orcid.org/0000-0002-5316-5533)
- Qun Yuan
- Yuan Yang (ORCID: https://orcid.org/0000-0003-2212-4023)
Institutions
- Hebei Medical University (CN)
- Harbin Medical University (CN)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
- Chongqing Maternal and Child Health Hospital (CN)
- Central Hospital of Zibo (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1007/s12672-025-03568-y
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00